| # | Drug | Count |
|---|---|---|
| 0 | TEMOZOLOMIDE | 312 |
| 1 | BEVACIZUMAB | 310 |
| 2 | LEVETIRACETAM | 166 |
| 3 | DEXAMETHASONE | 127 |
| 4 | DEXAMETHASONE 1.5 MG | 127 |
| 5 | ADALIMUMAB | 84 |
| 6 | METHOTREXATE SODIUM | 84 |
| 7 | METHOTREXATE | 79 |
| 8 | LEVETIRACETAM IN SODIUM CHLORIDE | 76 |
| 9 | LEVETIRACETAM INJECTION | 76 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEMIGATINIB | 14 | 0.0164 |
| 1 | LAROTRECTINIB | 14 | 0.0156 |
| 2 | TEMOZOLOMIDE | 312 | 0.0146 |
| 3 | LOMUSTINE | 37 | 0.0142 |
| 4 | DEXTRAN 40 | 1 | 0.0139 |
| 5 | FLUCICLOVINE F-18 | 1 | 0.0098 |
| 6 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 7 | BEVACIZUMAB-BVZR | 4 | 0.0057 |
| 8 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 9 | OLUTASIDENIB | 1 | 0.0035 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 361 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 336 |
| 2 | Corticosteroid [EPC] | 218 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 125 |
| 4 | Kinase Inhibitor [EPC] | 88 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 79 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 71 |
| 7 | Proton Pump Inhibitor [EPC] | 56 |
| 8 | Benzodiazepine [EPC] | 53 |
| 9 | Integrin Receptor Antagonist [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 14 | 0.0203 |
| 1 | Nuclear Export Inhibitor [EPC] | 20 | 0.0023 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 336 | 0.0018 |
| 3 | Alkylating Drug [EPC] | 361 | 0.0015 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 5 | Selectin Blocker [EPC] | 1 | 0.0007 |
| 6 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 7 | Radioactive Diagnostic Agent [EPC] | 2 | 0.0006 |
| 8 | Recombinant Human Growth Hormone [EPC] | 13 | 0.0006 |
| 9 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |